MCK

Thomas L. Rodgers

Known title: EVP, Chief Strategy & BDOCIK: 0001813684

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

McKesson Re-Rated on M&A Momentum Amid Strong Performance. McKesson shares have risen while the broader market fell, driven by renewed analyst interest in the company's increased M&A efforts. This positive sentiment aligns with recent recognition from financial commentators who view the healthcare stock as a strong performer. The stock's strength is further supported by a high RSI, indicating significant recent buying pressure.

this person other insiders at MCK

Transaction History

MCK▼ Sell$514K
MCK▼ Sell$90K
MCK▼ Sell$1.8M
MCK▲ Buy$0
MCK▼ Sell$179K
MCK▲ Buy$0
MCK▼ Sell$120K
MCK▲ Buy$0
MCK▼ Sell$97K
MCK▼ Sell$934K
MCK▲ Buy$0
MCK▼ Sell$225K
MCK▼ Sell$2.1M
MCK▼ Sell$366K
MCK▼ Sell$166K
MCK▲ Buy$0
MCK▲ Buy$0
MCK▼ Sell$168K
MCK▼ Sell$120K
MCK▲ Buy$0
MCK▲ Buy$0
MCK▼ Sell$887K
MCK▼ Sell$2.9M
MCK▼ Sell$73K
MCK▼ Sell$440K
MCK▲ Buy$0
MCK▼ Sell$196K
MCK▲ Buy$0
MCK▼ Sell$130K
MCK▲ Buy$0
MCK▼ Sell$131K
MCK▲ Buy$0
MCK▼ Sell$1.5M
MCK▼ Sell$255K
MCK▲ Buy$0
MCK▼ Sell$169K
MCK▼ Sell$2.3M
MCK▼ Sell$206K
MCK▼ Sell$140K
MCK▲ Buy$0
MCK▼ Sell$138K
MCK▲ Buy$0
MCK▼ Sell$92K
MCK▼ Sell$982K
MCK▲ Buy$0
MCK▼ Sell$477K
MCK▼ Sell$51K
MCK▲ Buy$0
MCK▼ Sell$136K
MCK▼ Sell$174K
MCK▼ Sell$116K
MCK▲ Buy$0
MCK▲ Buy$0
MCK▼ Sell$230K
MCK▼ Sell$68K
MCK▲ Buy$0
MCK▼ Sell$24K
MCK▲ Buy$0
MCK▼ Sell$83K

We use analytics to understand how market-wall is used. No personal data is sold.